Medicine · 2025
The treatment of amphotericin B-resistant C neoformans meningitis: A case report and literature review.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Long Liang, Yan Qingzi, Xiao Can, Liu Xiang, Yan Yi
Аннотация
RATIONALE: Cryptococcal meningitis is caused by Cryptococcus neoformans and Cryptococcus gattii, predominantly affects immunocompromised host. Resistance to amphotericin B poses therapeutic challenges, especially in immunocompetent individuals, where evidence is scarce.
PATIENT CONCERNS: This study reports a case of an old immunocompetent male diagnosed with amphotericin B-resistant C neoformans meningitis.
DIAGNOSES: Amphotericin B-resistant C neoformans meningitis.
INTERVENTIONS: Treatment failure occurred with both induction regimens (amphotericin B deoxycholate/fluconazole for 14 days followed by fluconazole/flucytosine for 29 days), then used salvage therapy combining amphotericin B colloidal dispersion (ABCD) in this amphotericin B-resistant C neoformans meningitis.
OUTCOMES: Successful salvage therapy with ABCD/flucytosine was achieved in a case of amphotericin B-resistant C neoformans meningitis. However, the patient ultimately succumbed to multidrug-resistant Klebsiella pneumoniae meningitis secondary to prolonged dexamethasone use for ABCD infusion reaction prophylaxis, which induced significant immunosuppression.
LESSONS: ABCD is a feasible alternative treatment for amphotericin B-resistant C neoformans meningitis. During prolonged ABCD therapy, pharmacists must implement pharmaceutical care to ensure medication safety and mitigate adverse effects, thereby preventing treatment discontinuation or treatment failure.
PATIENT CONCERNS: This study reports a case of an old immunocompetent male diagnosed with amphotericin B-resistant C neoformans meningitis.
DIAGNOSES: Amphotericin B-resistant C neoformans meningitis.
INTERVENTIONS: Treatment failure occurred with both induction regimens (amphotericin B deoxycholate/fluconazole for 14 days followed by fluconazole/flucytosine for 29 days), then used salvage therapy combining amphotericin B colloidal dispersion (ABCD) in this amphotericin B-resistant C neoformans meningitis.
OUTCOMES: Successful salvage therapy with ABCD/flucytosine was achieved in a case of amphotericin B-resistant C neoformans meningitis. However, the patient ultimately succumbed to multidrug-resistant Klebsiella pneumoniae meningitis secondary to prolonged dexamethasone use for ABCD infusion reaction prophylaxis, which induced significant immunosuppression.
LESSONS: ABCD is a feasible alternative treatment for amphotericin B-resistant C neoformans meningitis. During prolonged ABCD therapy, pharmacists must implement pharmaceutical care to ensure medication safety and mitigate adverse effects, thereby preventing treatment discontinuation or treatment failure.